Correction: Martins et al. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals 2022, 15, 210
Research Institute for Medicines (iMed.ULisboa), Universidade de Lisboa, 1649-003 Lisbon, Portugal; hribeiro@campus.ul.pt
Faculdade de Farmácia, Universidade de Lisboa, 1649-003 Lisbon, Portugal; analucia199867@gmail.com (A.L.G.); inesvb97@gmail.com (I.V.B.)
*Correspondence: amartins@farm-id.pt (A.M.M.); jmmarto@ff.ulisboa.pt (J.M.)The authors would like to make the following corrections about the published paper [1]. The changes are as follows:
- Missing Citation
In the original publication, refs. [2,3] was not cited. The citation has now been inserted in 4. The Skin Endocannabinoid System and the Use of Cannabinoids as a Potential Treatment for Skin Inflammatory Diseases, 4.1. The Skin Endocannabinoid System, Table 2 caption. Newly add references as [47,48] in the original paper, the order of some reference citation has been adjusted correspondingly.
“Table 2. The different classes of cannabinoids located in the skin, and some examples [15,37,47,48].”
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.